This list is based on the watchlists of people on Stock Events who follow FRNM. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
FAQs
What is Freenome stock price today?▼
The current price of FRNM is $12.23 USD — it has decreased by -2% in the past 24 hours. Watch Freenome stock price performance more closely on the chart.
What is Freenome stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Freenome stocks are traded under the ticker FRNM.
What is Freenome market cap?▼
Today Freenome has the market capitalization of 1.34B
When is the next Freenome earnings date?▼
Freenome is going to release the next earnings report on November 10, 2026.
What were Freenome earnings last quarter?▼
FRNM earnings for the last quarter are -1.91 USD per share, whereas the estimation was -1.78 USD resulting in a -7.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Freenome have?▼
As of November 2, 2026, the company has 378 employees.
In which sector is Freenome located?▼
Freenome operates in the Health & Wellness sector.
When did Freenome complete a stock split?▼
Freenome has not had any recent stock splits.
Where is Freenome headquartered?▼
Freenome is headquartered in NEW YORK, United States.